CAM
PRAX icon

Cormorant Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Cormorant Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$285M Sell
885,500
-64,500
-7% -$20M 14.33% 1
2025
Q4 		$280M Sell
950,000
-50,000
-5% -$9.31M 12.95% 1
2025
Q3 		$53M Sell
1,000,000
-625,000
-38% -$30.3M 3.66% 11
2025
Q2 		$68.3M Sell
1,625,000
-120,000
-7% -$4.57M 5.09% 4
2025
Q1 		$66.1M Buy
1,745,000
+51,781
+3% +$3.23M 4.97% 5
2024
Q4 		$130M Buy
1,693,219
+823,219
+95% +$59.6M 7.16% 2
2024
Q3 		$50.1M Buy
870,000
+185,000
+27% +$9.99M 2.65% 9
2024
Q2 		$28.3M Sell
685,000
-625,000
-48% -$29.5M 1.64% 19
2024
Q1 		$79.9M Buy
1,310,000
+676,655
+107% +$30.4M 3.51% 6
2023
Q4 		$14.1M Buy
633,345
+12
+0% +$216 0.67% 35
2023
Q3 		$16.2M Hold
633,333
– – 0.95% 27
2023
Q2 		$10.9M Buy
+633,333
New +$9.7M 0.61% 37
2022
Q2 		– Sell
-50,160
Closed -$7.68M – 85
2022
Q1 		$7.68M Hold
50,160
– – 0.59% 46
2021
Q4 		$14.8M Sell
50,160
-18,117
-27% -$5.31M 0.88% 32
2021
Q3 		$18.9M Buy
68,277
+1
+0% +$271 0.77% 37
2021
Q2 		$18.7M Sell
68,276
-3,334
-5% -$1.19M 0.64% 42
2021
Q1 		$35.2M Hold
71,610
– – 0.78% 34
2020
Q4 		$57.7M Buy
+71,610
New +$41.8M 1.37% 25

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cormorant Asset Management's PRAX Position: Q1 2026 in Review

Cormorant Asset Management reduced its Praxis Precision Medicines (PRAX) stake by 6.8% in Q1 2026, selling an estimated $20M and leaving 885,500 shares worth $285M. The position accounts for 14.33% of the portfolio, ranked #1.

Cormorant Asset Management first reported a position in PRAX in Q4 2020 and has held it in 18 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Cormorant Asset Management held 885,500 shares of Praxis Precision Medicines worth $285M as of Q1 2026.
  • Cormorant Asset Management sold 64,500 Praxis Precision Medicines shares in Q1 2026, an estimated $20M.
  • Praxis Precision Medicines made up 14.33% of Cormorant Asset Management's portfolio in Q1 2026, its #1 holding.
  • Cormorant Asset Management first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 18 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Cormorant Asset Management's 13F filing for Q1 2026, filed 15 May 2026.